The progress of early cancer diagnoses in clinical laboratories

December 26, 2024 Bullet Article

Early diagnosis of cancer is critically important for the ideal prognosis of cancer patients. cfDNA-based new technologies have the potential to be the methodology for liquid biopsy of early cancer patients. Dr Xu Songxiao of Zhejiang Cancer Hospital discusses the progress of cfDNA methylation, fragmentome and microbiome studies, as well as the combined application of current biomarkers in this talk at RED 2024.

 

More on same topic

Select a related post from the options below.

Recommended topics

SequencingRED 2020Rare Diseases
Next Read
Scroll to Top